Jun Wang
Jun Wang is a research investigator, at Millennium Pharmaceuticals, Inc., 40 Landsdowne St., Cambridge, MA 02144, USA.
Articles
A New Approach to Forced Degradation Studies Using Anhydrous Conditions
March 2nd 2014In this article, the authors demonstrate that a normal-phase chromatographic method was stability-indicating for a water-sensitive prodrug. The stress conditions using aqueous and non-aqueous conditions were also compared to understand the information obtained with each approach.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 21st 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 21st 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 21st 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 21st 2024
Exploring Opportunities for LNP Delivery in mRNA
